These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 8674469)
1. [The dopamine transporter: characterization and physiopathologic implications]. Thibaut F; Vaugeois JM; Petit M Encephale; 1995; 21(6):445-51. PubMed ID: 8674469 [TBL] [Abstract][Full Text] [Related]
2. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884 [TBL] [Abstract][Full Text] [Related]
3. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Volkow ND; Wang GJ; Fischman MW; Foltin RW; Fowler JS; Abumrad NN; Vitkun S; Logan J; Gatley SJ; Pappas N; Hitzemann R; Shea CE Nature; 1997 Apr; 386(6627):827-30. PubMed ID: 9126740 [TBL] [Abstract][Full Text] [Related]
4. The dopamine transporter: a crucial component regulating dopamine transmission. Jaber M; Jones S; Giros B; Caron MG Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041 [TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Wilson JM; Levey AI; Bergeron C; Kalasinsky K; Ang L; Peretti F; Adams VI; Smialek J; Anderson WR; Shannak K; Deck J; Niznik HB; Kish SJ Ann Neurol; 1996 Sep; 40(3):428-39. PubMed ID: 8797532 [TBL] [Abstract][Full Text] [Related]
6. Rapid regulation of the dopamine transporter: role in stimulant addiction? Zahniser NR; Sorkin A Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127 [TBL] [Abstract][Full Text] [Related]
7. Molecular, functional and biochemical characteristics of the dopamine transporter: regional differences and clinical relevance. Hitri A; Hurd YL; Wyatt RJ; Deutsch SI Clin Neuropharmacol; 1994 Feb; 17(1):1-22. PubMed ID: 8149355 [TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study. Sossi V; de la Fuente-Fernández R; Schulzer M; Troiano AR; Ruth TJ; Stoessl AJ Ann Neurol; 2007 Nov; 62(5):468-74. PubMed ID: 17886297 [TBL] [Abstract][Full Text] [Related]
9. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice. Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881 [TBL] [Abstract][Full Text] [Related]
10. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism. Volz TJ; Schenk JO Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864 [TBL] [Abstract][Full Text] [Related]
11. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue. Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005 [TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity. Van Kampen JM; McGeer EG; Stoessl AJ Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039 [TBL] [Abstract][Full Text] [Related]
14. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake. Storch A; Hwang YI; Gearhart DA; Beach JW; Neafsey EJ; Collins MA; Schwarz J J Neurochem; 2004 May; 89(3):685-94. PubMed ID: 15086525 [TBL] [Abstract][Full Text] [Related]
15. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
16. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. Brown JM; Hanson GR; Fleckenstein AE J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904 [TBL] [Abstract][Full Text] [Related]
17. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501 [TBL] [Abstract][Full Text] [Related]
19. [Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation]. Jaber M; Bloch B; Caron MG; Giros B C R Seances Soc Biol Fil; 1998; 192(6):1127-37. PubMed ID: 10101608 [TBL] [Abstract][Full Text] [Related]
20. Changes in dopamine transporter and c-Fos expression in the nucleus accumbens of alcohol-tolerant rats. Yoshimoto K; Ueda S; Nishi M; Yang Y; Matsushita H; Takeuchi Y; Kato B; Kawai Y; Noritake K; Kaneda S; Sorimachi Y; Yasuhara M Alcohol Clin Exp Res; 2000 Mar; 24(3):361-5. PubMed ID: 10776677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]